| Literature DB >> 31523510 |
Md Javed Foysal1,2, Thi Thu Thuy Nguyen1, Md Reaz Chaklader1, Muhammad A B Siddik1,3, Chin-Yen Tay4, Ravi Fotedar1, Sanjay Kumar Gupta5.
Abstract
This study aimed to investigate the effects of Clostridium butyricum as a dietary probiotic supplement in fishmeal based diet on growth, gut microbiota and immune performance of marron (Cherax cainii). Marron were randomly distributed into two different treatment groups, control and probiotic fed group. After 42 days of feeding trial, the results revealed a significant (P < 0.05) increase in growth due to increase in number of moults in marron fed probiotics. The probiotic diet also significantly enhanced the total haemocyte counts (THC), lysozyme activity in the haemolymph and protein content of the tail muscle in marron. Compared to control, the 16S rRNA sequences data demonstrated an enrichment of bacterial diversity in the probiotic fed marron where significant increase of Clostridium abundance was observed. The abundance for crayfish pathogen Vibrio and Aeromonas were found to be significantly reduced post feeding with probiotic diet. Predicted metabolic pathway revealed an increased activity for the metabolism and absorption of carbohydrate, degradation of amino acid, fatty acid and toxic compounds, and biosynthesis of secondary metabolites. C. butyricum supplementation also significantly modulated the expression level of immune-responsive genes of marron post challenged with Vibrio mimicus. The overall results suggest that C. butyricum could be used as dietary probiotic supplement in marron aquaculture.Entities:
Keywords: Bioinformatics; Gene expression profiling; Health and immune indices; High throughput sequencing; Marron; Probiotic bacteria
Year: 2019 PMID: 31523510 PMCID: PMC6716501 DOI: 10.7717/peerj.7553
Source DB: PubMed Journal: PeerJ ISSN: 2167-8359 Impact factor: 2.984
Feed ingredients and proximate composition (% dry weight) of the diet used in this study.
| Fishmeal | 41 |
| Soya bean meal | 10 |
| Wheat | 37 |
| Corn starch | 4.80 |
| Cod liver oil | 4.20 |
| CaCO3 | 0.02 |
| Vitamin premix | 0.23 |
| Vitamin C | 0.05 |
| Cholesterol | 0.50 |
| Lecithin-Soy | 1 |
| Betacaine | 1.20 |
| Total | 100 |
| 29.93 | |
| 7.12 | |
| 18.21 | |
| 1.01 × 107 |
Notes.
All ingredients were procured and feeds were formulated by Glen Forest Specialty Feeds, Western Australia.
crude protein
gross energy
Mega joule
Final proximate composition of the experimental diet.
Primers used for gene expression analysis in present study.
| Reverse sequence (5′–3′) | |||
|---|---|---|---|
| proPO | |||
| cytMnSOD | |||
| PcCTSL | CGGATCACTGGAGGGTCAAACACTT | GCAATTTTCATCCTCGGCATCAT | |
| IL-8 | CTATTGTGGTGTTCCTGA | TCTTCACCCAGGGAGCTTC | |
| IL-10 | CAGTGCAGAAGAGTCGACTGCAAG | CGCTTGAGATCCTGAAATATA | |
| IL-17F | GTCTCTGTCACCGTGGAC | TGGGCCTCACACAGGTACA | |
| β-actin | TTGAGCAGGAGATGGGAACCG | AGAGCCTCAGGGCAACGGAAA |
Notes.
Interleukin
Cathepsin L
Prophenoloxidase
Cytosolic manganese superoxide dismutase
Mean ± SE of some health parameters of marron after feeding trials.
| WG | 21.66 ± 1.78 | 26.24 ± 0.81 |
| SGR | 0.45 ± 0.034 | 0.53 ± 0.031 |
| Protein | 84.4 ± 0.57 | 88.7 ± 0.83 |
| Energy | 20038.8 ± 56.06 | 20241.1 ± 88.25 |
| Fat | 8.8 ± 0.09 | 8.4 ± 0.06 |
| Lysozyme | 0.42 ± 0.005 | 0.48 ± 0.009 |
| THC | 8.2 ± 0.09 | 9.5 ± 0.21 |
| HO | 0.41 ± 0.004 | 0.44 ± 0.011 |
Notes.
weight gain
specific growth rate
hepatopancreas moisture
total haemocyte count
haemolymph osmolality
Significantly different at α-level of 0.05.
From tail muscle.
From hepatopancreas.
Figure 1(A) Multiple regression analysis showing the relationship between the number of moults and health indices of marron after trial; (B) PCoA plot displaying the separation of marron regarding moult counts in two different feeding conditions.
Figure 2PCoA plot representing the impacts of two different feeds on gut microbial communities of marron after 42 days of feeding trial.
Figure 3(A) Venn diagram showing shared and unshared genus in two different groups; (B) box plots exhibiting the species richness in two different feeding conditions after trial.
Figure 4Microbial communities in two different fed groups after trial; (A) relative abundance of bacterial OTUs at phylum level; (B) Relative abundance of bacterial OTUs at genus level.
Diversity index (Mean SE) of bacterial genus in marron gut after feeding trials.
| Control | 15.8 (1.9) | 1.51 (0.1) | 0.69 (0.1) | 7.59 (0.2) | 86.74 (5.8) |
| Probiotic | 30.3 (11.5) | 3.19 (0.1) | 0.82 (0.1) | 16.7 (2.1) | 128.48 (8.6) |
Notes.
Significantly different at α-level of 0.05.
Significantly different at α-level of 0.005.
Significantly different at α-level of 0.001.
Figure 5(A) Indicator bacterial genus in two different conditions (control and probiotic) with LDA value 2.0 or more; (B) predicted metabolic pathways in two different fed groups revealed from 16S rRNA sequence data using Piphillin and the LEfSe package.
Figure 6Barplot showing the relative expression level of immune genes in marron intestine tissue after feeding trial.
* Significantly different at α-level of 0.05. **Significantly different at α-level of 0.005.